In 2019, the global antiviral drug market was approximately US$ 56.4 billion, while Anti-hepatitis virus drugs accounted for about 38%, closed to USD$ 21 billion.
This report aims to provide a comprehensive presentation of the global market for Anti Hepatitis Virus Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti Hepatitis Virus Drugs. This report contains market size and forecasts of Anti Hepatitis Virus Drugs in global, including the following market information:
Global Anti Hepatitis Virus Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Anti Hepatitis Virus Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Nucleos(t)ide Analogues Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anti Hepatitis Virus Drugs include Novartis, Roche, Bristol Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Merck, AbbVie, Gilead Sciences and CHIATAI TIANQING, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti Hepatitis Virus Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti Hepatitis Virus Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Anti Hepatitis Virus Drugs Market Segment Percentages, by Type, 2022 (%)
Nucleos(t)ide Analogues
Direct-acting Antiviral Dgents (DAAs)
Interferon Alfa
Global Anti Hepatitis Virus Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Anti Hepatitis Virus Drugs Market Segment Percentages, by Application, 2022 (%)
Hepatitis B
HCV
Other
Global Anti Hepatitis Virus Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Anti Hepatitis Virus Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti Hepatitis Virus Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Anti Hepatitis Virus Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Roche
Bristol Myers Squibb
GlaxoSmithKline
Johnson & Johnson
Merck
AbbVie
Gilead Sciences
CHIATAI TIANQING
Cosunter Pharmaceutical
Qingfeng Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti Hepatitis Virus Drugs, market overview.
Chapter 2: Global Anti Hepatitis Virus Drugs market size in revenue.
Chapter 3: Detailed analysis of Anti Hepatitis Virus Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti Hepatitis Virus Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti Hepatitis Virus Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti Hepatitis Virus Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti Hepatitis Virus Drugs Overall Market Size
2.1 Global Anti Hepatitis Virus Drugs Market Size: 2022 VS 2029
2.2 Global Anti Hepatitis Virus Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti Hepatitis Virus Drugs Players in Global Market
3.2 Top Global Anti Hepatitis Virus Drugs Companies Ranked by Revenue
3.3 Global Anti Hepatitis Virus Drugs Revenue by Companies
3.4 Top 3 and Top 5 Anti Hepatitis Virus Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Anti Hepatitis Virus Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti Hepatitis Virus Drugs Players in Global Market
3.6.1 List of Global Tier 1 Anti Hepatitis Virus Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Anti Hepatitis Virus Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti Hepatitis Virus Drugs Market Size Markets, 2022 & 2029
4.1.2 Nucleos(t)ide Analogues
4.1.3 Direct-acting Antiviral Dgents (DAAs)
4.1.4 Interferon Alfa
4.2 By Type - Global Anti Hepatitis Virus Drugs Revenue & Forecasts
4.2.1 By Type - Global Anti Hepatitis Virus Drugs Revenue, 2018-2023
4.2.2 By Type - Global Anti Hepatitis Virus Drugs Revenue, 2024-2029
4.2.3 By Type - Global Anti Hepatitis Virus Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti Hepatitis Virus Drugs Market Size, 2022 & 2029
5.1.2 Hepatitis B
5.1.3 HCV
5.1.4 Other
5.2 By Application - Global Anti Hepatitis Virus Drugs Revenue & Forecasts
5.2.1 By Application - Global Anti Hepatitis Virus Drugs Revenue, 2018-2023
5.2.2 By Application - Global Anti Hepatitis Virus Drugs Revenue, 2024-2029
5.2.3 By Application - Global Anti Hepatitis Virus Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Anti Hepatitis Virus Drugs Market Size, 2022 & 2029
6.2 By Region - Global Anti Hepatitis Virus Drugs Revenue & Forecasts
6.2.1 By Region - Global Anti Hepatitis Virus Drugs Revenue, 2018-2023
6.2.2 By Region - Global Anti Hepatitis Virus Drugs Revenue, 2024-2029
6.2.3 By Region - Global Anti Hepatitis Virus Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Anti Hepatitis Virus Drugs Revenue, 2018-2029
6.3.2 US Anti Hepatitis Virus Drugs Market Size, 2018-2029
6.3.3 Canada Anti Hepatitis Virus Drugs Market Size, 2018-2029
6.3.4 Mexico Anti Hepatitis Virus Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Anti Hepatitis Virus Drugs Revenue, 2018-2029
6.4.2 Germany Anti Hepatitis Virus Drugs Market Size, 2018-2029
6.4.3 France Anti Hepatitis Virus Drugs Market Size, 2018-2029
6.4.4 U.K. Anti Hepatitis Virus Drugs Market Size, 2018-2029
6.4.5 Italy Anti Hepatitis Virus Drugs Market Size, 2018-2029
6.4.6 Russia Anti Hepatitis Virus Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Anti Hepatitis Virus Drugs Market Size, 2018-2029
6.4.8 Benelux Anti Hepatitis Virus Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Anti Hepatitis Virus Drugs Revenue, 2018-2029
6.5.2 China Anti Hepatitis Virus Drugs Market Size, 2018-2029
6.5.3 Japan Anti Hepatitis Virus Drugs Market Size, 2018-2029
6.5.4 South Korea Anti Hepatitis Virus Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Anti Hepatitis Virus Drugs Market Size, 2018-2029
6.5.6 India Anti Hepatitis Virus Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Anti Hepatitis Virus Drugs Revenue, 2018-2029
6.6.2 Brazil Anti Hepatitis Virus Drugs Market Size, 2018-2029
6.6.3 Argentina Anti Hepatitis Virus Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anti Hepatitis Virus Drugs Revenue, 2018-2029
6.7.2 Turkey Anti Hepatitis Virus Drugs Market Size, 2018-2029
6.7.3 Israel Anti Hepatitis Virus Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Anti Hepatitis Virus Drugs Market Size, 2018-2029
6.7.5 UAE Anti Hepatitis Virus Drugs Market Size, 2018-2029
7 Anti Hepatitis Virus Drugs Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Anti Hepatitis Virus Drugs Major Product Offerings
7.1.4 Novartis Anti Hepatitis Virus Drugs Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Anti Hepatitis Virus Drugs Major Product Offerings
7.2.4 Roche Anti Hepatitis Virus Drugs Revenue in Global Market (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Bristol Myers Squibb
7.3.1 Bristol Myers Squibb Company Summary
7.3.2 Bristol Myers Squibb Business Overview
7.3.3 Bristol Myers Squibb Anti Hepatitis Virus Drugs Major Product Offerings
7.3.4 Bristol Myers Squibb Anti Hepatitis Virus Drugs Revenue in Global Market (2018-2023)
7.3.5 Bristol Myers Squibb Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Anti Hepatitis Virus Drugs Major Product Offerings
7.4.4 GlaxoSmithKline Anti Hepatitis Virus Drugs Revenue in Global Market (2018-2023)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Anti Hepatitis Virus Drugs Major Product Offerings
7.5.4 Johnson & Johnson Anti Hepatitis Virus Drugs Revenue in Global Market (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Merck
7.6.1 Merck Company Summary
7.6.2 Merck Business Overview
7.6.3 Merck Anti Hepatitis Virus Drugs Major Product Offerings
7.6.4 Merck Anti Hepatitis Virus Drugs Revenue in Global Market (2018-2023)
7.6.5 Merck Key News & Latest Developments
7.7 AbbVie
7.7.1 AbbVie Company Summary
7.7.2 AbbVie Business Overview
7.7.3 AbbVie Anti Hepatitis Virus Drugs Major Product Offerings
7.7.4 AbbVie Anti Hepatitis Virus Drugs Revenue in Global Market (2018-2023)
7.7.5 AbbVie Key News & Latest Developments
7.8 Gilead Sciences
7.8.1 Gilead Sciences Company Summary
7.8.2 Gilead Sciences Business Overview
7.8.3 Gilead Sciences Anti Hepatitis Virus Drugs Major Product Offerings
7.8.4 Gilead Sciences Anti Hepatitis Virus Drugs Revenue in Global Market (2018-2023)
7.8.5 Gilead Sciences Key News & Latest Developments
7.9 CHIATAI TIANQING
7.9.1 CHIATAI TIANQING Company Summary
7.9.2 CHIATAI TIANQING Business Overview
7.9.3 CHIATAI TIANQING Anti Hepatitis Virus Drugs Major Product Offerings
7.9.4 CHIATAI TIANQING Anti Hepatitis Virus Drugs Revenue in Global Market (2018-2023)
7.9.5 CHIATAI TIANQING Key News & Latest Developments
7.10 Cosunter Pharmaceutical
7.10.1 Cosunter Pharmaceutical Company Summary
7.10.2 Cosunter Pharmaceutical Business Overview
7.10.3 Cosunter Pharmaceutical Anti Hepatitis Virus Drugs Major Product Offerings
7.10.4 Cosunter Pharmaceutical Anti Hepatitis Virus Drugs Revenue in Global Market (2018-2023)
7.10.5 Cosunter Pharmaceutical Key News & Latest Developments
7.11 Qingfeng Pharmaceutical
7.11.1 Qingfeng Pharmaceutical Company Summary
7.11.2 Qingfeng Pharmaceutical Business Overview
7.11.3 Qingfeng Pharmaceutical Anti Hepatitis Virus Drugs Major Product Offerings
7.11.4 Qingfeng Pharmaceutical Anti Hepatitis Virus Drugs Revenue in Global Market (2018-2023)
7.11.5 Qingfeng Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Anti Hepatitis Virus Drugs Market Opportunities & Trends in Global Market
Table 2. Anti Hepatitis Virus Drugs Market Drivers in Global Market
Table 3. Anti Hepatitis Virus Drugs Market Restraints in Global Market
Table 4. Key Players of Anti Hepatitis Virus Drugs in Global Market
Table 5. Top Anti Hepatitis Virus Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Anti Hepatitis Virus Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Anti Hepatitis Virus Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Anti Hepatitis Virus Drugs Product Type
Table 9. List of Global Tier 1 Anti Hepatitis Virus Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti Hepatitis Virus Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Anti Hepatitis Virus Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Anti Hepatitis Virus Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Anti Hepatitis Virus Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Anti Hepatitis Virus Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Anti Hepatitis Virus Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Anti Hepatitis Virus Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Novartis Company Summary
Table 31. Novartis Anti Hepatitis Virus Drugs Product Offerings
Table 32. Novartis Anti Hepatitis Virus Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis Key News & Latest Developments
Table 34. Roche Company Summary
Table 35. Roche Anti Hepatitis Virus Drugs Product Offerings
Table 36. Roche Anti Hepatitis Virus Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Roche Key News & Latest Developments
Table 38. Bristol Myers Squibb Company Summary
Table 39. Bristol Myers Squibb Anti Hepatitis Virus Drugs Product Offerings
Table 40. Bristol Myers Squibb Anti Hepatitis Virus Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Bristol Myers Squibb Key News & Latest Developments
Table 42. GlaxoSmithKline Company Summary
Table 43. GlaxoSmithKline Anti Hepatitis Virus Drugs Product Offerings
Table 44. GlaxoSmithKline Anti Hepatitis Virus Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. GlaxoSmithKline Key News & Latest Developments
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Anti Hepatitis Virus Drugs Product Offerings
Table 48. Johnson & Johnson Anti Hepatitis Virus Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Anti Hepatitis Virus Drugs Product Offerings
Table 52. Merck Anti Hepatitis Virus Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. AbbVie Company Summary
Table 55. AbbVie Anti Hepatitis Virus Drugs Product Offerings
Table 56. AbbVie Anti Hepatitis Virus Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. AbbVie Key News & Latest Developments
Table 58. Gilead Sciences Company Summary
Table 59. Gilead Sciences Anti Hepatitis Virus Drugs Product Offerings
Table 60. Gilead Sciences Anti Hepatitis Virus Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Gilead Sciences Key News & Latest Developments
Table 62. CHIATAI TIANQING Company Summary
Table 63. CHIATAI TIANQING Anti Hepatitis Virus Drugs Product Offerings
Table 64. CHIATAI TIANQING Anti Hepatitis Virus Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. CHIATAI TIANQING Key News & Latest Developments
Table 66. Cosunter Pharmaceutical Company Summary
Table 67. Cosunter Pharmaceutical Anti Hepatitis Virus Drugs Product Offerings
Table 68. Cosunter Pharmaceutical Anti Hepatitis Virus Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Cosunter Pharmaceutical Key News & Latest Developments
Table 70. Qingfeng Pharmaceutical Company Summary
Table 71. Qingfeng Pharmaceutical Anti Hepatitis Virus Drugs Product Offerings
Table 72. Qingfeng Pharmaceutical Anti Hepatitis Virus Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Qingfeng Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Anti Hepatitis Virus Drugs Segment by Type in 2022
Figure 2. Anti Hepatitis Virus Drugs Segment by Application in 2022
Figure 3. Global Anti Hepatitis Virus Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti Hepatitis Virus Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anti Hepatitis Virus Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti Hepatitis Virus Drugs Revenue in 2022
Figure 8. By Type - Global Anti Hepatitis Virus Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Anti Hepatitis Virus Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Anti Hepatitis Virus Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Anti Hepatitis Virus Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Anti Hepatitis Virus Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Anti Hepatitis Virus Drugs Revenue Market Share, 2018-2029
Figure 16. US Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Anti Hepatitis Virus Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Anti Hepatitis Virus Drugs Revenue Market Share, 2018-2029
Figure 28. China Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Anti Hepatitis Virus Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Anti Hepatitis Virus Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Anti Hepatitis Virus Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Novartis Anti Hepatitis Virus Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Roche Anti Hepatitis Virus Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bristol Myers Squibb Anti Hepatitis Virus Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. GlaxoSmithKline Anti Hepatitis Virus Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Johnson & Johnson Anti Hepatitis Virus Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Merck Anti Hepatitis Virus Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. AbbVie Anti Hepatitis Virus Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Gilead Sciences Anti Hepatitis Virus Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. CHIATAI TIANQING Anti Hepatitis Virus Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Cosunter Pharmaceutical Anti Hepatitis Virus Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Qingfeng Pharmaceutical Anti Hepatitis Virus Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
